|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,906.00 GBX | +0.59% |
|
+8.05% | +8.09% |
| 02-12 | AbbVie sues US health agency over Botox price controls | RE |
| 02-12 | ASTRAZENECA : DZ Bank remains Neutral | ZD |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 31.88x | 7.03x | 0.78x | 5.72x | 17.06x | 17.83x | 1.61% | 314B | ||
| 45.03x | 34x | 0.49x | 14.66x | 32.51x | 35.36x | 0.58% | 909B | ||
| 21.88x | 7.41x | 0.24x | 6.45x | 17.93x | 19.67x | 2.14% | 580B | ||
| 61.68x | 21158.05x | 1.24x | 7.33x | 18.16x | 18.69x | 2.96% | 390B | ||
| 18.46x | 6.45x | 0.9x | 4.66x | 11.57x | 13.08x | 2.82% | 370B | ||
| 21.04x | 6.45x | 4.06x | 5.88x | 14.48x | 15.41x | 2.75% | 305B | ||
| 15.41x | 5.38x | 1.03x | 4.95x | 10.8x | 11.99x | 2.71% | 296B | ||
| 14.71x | 6.24x | -1.56x | 5.03x | 10.56x | 12.31x | 3.54% | 216B | ||
| 28.48x | 21.82x | 0.41x | 6.66x | 11.4x | 15.3x | 2.61% | 197B | ||
| 22.85x | 8.58x | 0.01x | 7.06x | 12.91x | 15.6x | 2.13% | 193B | ||
| 13.52x | 1.74x | 0.3x | 3.25x | 8.05x | 9.49x | 6.17% | 158B | ||
| 14.91x | 6.23x | -0.08x | 3.25x | 10.12x | 10.68x | 4.11% | 122B | ||
| 15.48x | 6x | 0.13x | 3.09x | 8.94x | 10.41x | 3.01% | 118B | ||
| 12.3x | 1.29x | 0.27x | 2.57x | 8.4x | 9.27x | 4.98% | 118B | ||
| 29.77x | 6.16x | -0.04x | 8.95x | 19.18x | 20.04x | -.--% | 117B | ||
| 34.69x | 7.5x | 3.31x | 11.19x | 21.99x | 23.44x | 2.81% | 96.85B | ||
| 51.1x | 1.28x | 0.86x | 2.85x | 10.83x | 30.38x | 3.58% | 57.5B | ||
| 44.78x | 6.38x | 1.42x | 10.65x | 35.38x | 36.93x | 0.47% | 56.55B | ||
| 142.46x | 1.38x | -1.27x | 1.69x | 8.11x | 13.99x | 0.24% | 53.77B | ||
| 23.07x | 2.2x | 1.89x | 3.94x | 15.63x | 17.48x | 1.74% | 49.38B | ||
| Average | 33.18x | 1,065.08x | 0.72x | 5.99x | 15.20x | 17.87x | 2.55% | 235.88B | |
| Weighted average by Cap. | 31.17x | 1,762.51x | 0.74x | 7.47x | 17.82x | 19.80x | 2.29% |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















